¼¼°èÀÇ ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀå
Pediatric Interventional Cardiology Devices
»óǰÄÚµå : 1761012
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 30¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 30¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼±Ãµ¼º ½É°á¼Õ Æó¼â ±â±â´Â CAGR 4.5%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 1,760¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀåÀº 2024³â¿¡´Â 6¾ï 1,760¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 9,130¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.9%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.6%¿Í 4.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

±â¼úÀÇ ¹ßÀüÀº ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿Ã °ÍÀΰ¡?

¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀåÀº ¼Ò¾Æ ¼±Ãµ¼º ½ÉÀ庴(CHD)ÀÇ Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â ±â¼ú ¹ßÀüÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ¼Ò¾Æ ȯÀÚÀÇ ½ÉÀå ÁúȯÀ» ÃÖ¼Òħ½ÀÀû ±â¼ú·Î Áø´Ü ¹× Ä¡·áÇϵµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ȸº¹ ½Ã°£ÀÌ Âª°í ÇÕº´Áõ À§ÇèÀÌ ³·¾Æ ±âÁ¸ °³½É¼úº¸´Ù ¼±È£µÇ°í ÀÖ½À´Ï´Ù. »ýüÈí¼ö¼º ½ºÅÙÆ®, ÷´Ü dz¼± Ä«Å×ÅÍ, Â÷¼¼´ë Æó¼â ±â±â¿Í °°Àº ±â¼ú Çõ½ÅÀ¸·Î º¸´Ù Á¤¹ÐÇÏ°í º¹ÀâÇÑ ½ÉÀå ¼ö¸®°¡ °¡´ÉÇØÁ³À¸¸ç, 3D ½ÉÃÊÀ½ÆÄ ¹× ÷´Ü ½ÉÀå MRI ½Ã½ºÅÛ°ú °°Àº ¿µ»ó ±â¼úÀÌ ¼Ò¾Æ ÁßÀç½Ã¼ú¿¡ µµÀÔµÇ¾î º¹ÀâÇÑ ½Ã¼úÀ» º¸´Ù Àß ½Ã°¢È­ÇÏ¿© °èȹÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °èȹÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ±â±âÀÇ ¼ÒÇüÈ­·Î ÀÎÇØ ´õ ÀÛÀº ¾î¸°ÀÌ¿Í ¿µ¾Æ¿¡ ´ëÇÑ ÁßÀç½Ã¼úÀÌ °¡´ÉÇØÁ³À¸¸ç, ÀÌ·¯ÇÑ ±â±â´Â ´õ ÀÛÀº ÇØºÎÇÐÀû ±¸Á¶¿¡¼­µµ È¿°úÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½Ã¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó º¹ÀâÇÑ ½ÉÀå ÁúȯÀ» °¡Áø ¼Ò¾Æ ȯÀڵ鿡°Ô »õ·Î¿î Ä¡·á °¡´É¼ºÀ» ¿­¾îÁÝ´Ï´Ù.

¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Àü ¼¼°èÀûÀ¸·Î ¼±Ãµ¼º ½ÉÀ庴(CHD)ÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, CHD´Â ¿©ÀüÈ÷ °¡Àå ÈçÇÑ ¼±Ãµ¼º ½ÉÀ庴À¸·Î Àü ¼¼°è Ãâ»ý¾ÆÀÇ ¾à 1%°¡ ¾Î°í ÀÖÀ¸¸ç, ¸¹Àº °æ¿ì »ýÈÄ Ãʱ⿡ ÀÇ·áÀû °³ÀÔÀÌ ÇÊ¿äÇÑ ÁúȯÀÔ´Ï´Ù. Áø´Ü ´É·ÂÀÌ Çâ»óµÇ°í ´õ ¸¹Àº CHD »ç·Ê°¡ Á¶±â¿¡ ¹ß°ßµÇ°í Ä¡·áµÊ¿¡ µû¶ó ¼Ò¾Æ ½ÉÇ÷°ü Àü¹® ÀåºñÀÇ Çʿ伺Àº °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å»ý¾Æ ÀÇ·áÀÇ ¹ßÀü°ú ¹Ì¼÷¾Æ ¹× ¹Ì¼÷¾Æ Ä¡·áÀÇ ¼º°øÀ¸·Î ÀÎÇØ ½ÉÇ÷°ü ÁßÀç½Ã¼ú ½Ã¼úÀÌ ÇÊ¿äÇÑ È¯ÀÚ±ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â´Â ÃÖ¼Òħ½ÀÀû Ä¡·á ¿É¼ÇÀ» Á¦°øÇϴµ¥, ƯÈ÷ ÀÌ·± ¾î¸° ȯ¾Æµé¿¡°Ô ¸Å¿ì Áß¿äÇϸç, CHD¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â ¹ß°ßÀ» À§ÇÑ ½ºÅ©¸®´× ¹æ¹ýÀÌ °³¼±µÈ °Íµµ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ¼Ò¾Æ ½ÉÀå Àü¹® Ä¡·áÀÇ Çʿ伺À» ÀνÄÇÏ°í ¼Ò¾Æ ¼øÈ¯±â ÇÁ·Î±×·¥¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼Ò¾Æ Àü¿ë ÁßÀç½Ã¼ú Àåºñ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ȯÀÚ Ä¡·á µ¿Çâ°ú ±ÔÁ¦ ½ÂÀÎÀº ¼Ò¾Æ ½ÉÀ庴 ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

ȯÀÚ Áß½ÉÀÇ ÀÇ·á Æ®·»µå¿Í ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ƯÈ÷ Å©±â, À¯¿¬¼º, »ýüÀûÇÕ¼º Ãø¸é¿¡¼­ ¼Ò¾Æ ȯÀÚÀÇ Æ¯¼öÇÑ ¿ä±¸¿¡ ¸Â´Â ±â±â °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú À¯·´ÀǾàǰû(EMA) µî ±ÔÁ¦ ±â°üÀº ¼Ò¾Æ ±â±â°¡ ¾ö°ÝÇÑ ¾ÈÀü¼º°ú À¯È¿¼º ±âÁØÀ» ÃæÁ·ÇÏ´Â °ÍÀ» ´õ¿í Áß¿äÇÏ°Ô ¿©±â°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¼ºÀÎ¿ë ±â±âÀÇ ¿ëµµ ÀüȯÀÌ ¾Æ´Ñ ¼Ò¾Æ Àü¿ë ÀÓ»ó½ÃÇèÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼Ò¾Æ Àü¿ë ÀÓ»ó½ÃÇèÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡Ä¡ ±â¹Ý ÇコÄɾîÀÇ Ãß¼¼´Â ȯÀÚ °á°ú¸¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¹Ýº¹ÀûÀÎ °³ÀÔÀÇ Çʿ伺À» ÃÖ¼ÒÈ­ÇÏ¿© Àå±âÀûÀ¸·Î ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ È¯ÀÚÀÇ °á°ú¿Í ÁßÀç ÈÄ »îÀÇ ÁúÀ» Áß¿ä½ÃÇÏ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ ±âÁØÀ» ÃæÁ·ÇÏ´Â ÃÖ÷´Ü ¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼Ò¾Æ¿ë ½ÉÇ÷°ü ÁßÀç½Ã¼ú ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, ¼±Ãµ¼º ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡, ±ÔÁ¦ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ÃÖ¼Òħ½ÀÀû ±â¼úÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ±âÁ¸ ¼ö¼úÀÇ À§Çè°ú ȸº¹ ½Ã°£À» ÁÙ¿© ¼Ò¾Æ Ä¡·á¿¡ ´õ¿í ¸Å·ÂÀûÀ̱⠶§¹®¿¡ ÀÌ·¯ÇÑ Àåºñ°¡ ´õ¿í ¸Å·ÂÀûÀ̶ó´Â °ÍÀÔ´Ï´Ù. »ýüÈí¼ö¼º ½ºÅÙÆ® ¹× °³¼±µÈ Ä«Å×ÅÍ ½Ã½ºÅÛÀÇ °³¹ß°ú °°Àº ±â¼úÀû Áøº¸·Î ÀÎÇØ º¸´Ù È¿°úÀûÀÌ°í ¾ÈÀüÇÑ Ä¡·á°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ, ¼±Ãµ¼º ½ÉÀ庴ÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ´õ ¸¹Àº ¾î¸°À̵éÀÌ ´õ ¾î¸° ³ªÀÌ¿¡ Ä¡·á¸¦ ¹Þ°í ÀÖ¾î ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ½ÉÀ庴 ÇÁ·Î±×·¥ ¹× ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ½Å»ý¾Æ ¹× ¼Ò¾Æ ÀÇ·á °³¼±¿¡ ´ëÇÑ Á¤ºÎÀÇ ³ë·ÂÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ¼Ò¾Æ ½ÉÀå ½Ã¼úÀÇ Á¤È®¼º°ú °á°ú¸¦ °³¼±ÇÏ´Â ¿µ»ó ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ȯÀÚ Ä¡·á¸¦ °³¼±ÇÒ ¼ö Àִ ÷´Ü ¼Ö·ç¼ÇÀ» °è¼Ó ã°í Àֱ⠶§¹®¿¡ ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

ºÎ¹®(¼±Ãµ¼º ½É°á¼Õ Æó¼â ±â±â, °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸·, ±âŸ ºÎ¹®)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 41°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pediatric Interventional Cardiology Devices Market to Reach US$3.0 Billion by 2030

The global market for Pediatric Interventional Cardiology Devices estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Transcatheter Heart Valves segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$617.6 Million While China is Forecast to Grow at 7.9% CAGR

The Pediatric Interventional Cardiology Devices market in the U.S. is estimated at US$617.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$691.3 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Pediatric Interventional Cardiology Devices Market - Key Trends & Drivers Summarized

How Are Technological Advancements Revolutionizing Pediatric Interventional Cardiology Devices?

The pediatric interventional cardiology devices market has seen significant technological advancements, leading to improved outcomes in the treatment of congenital heart diseases (CHD) in children. These devices are designed to diagnose and treat heart conditions in pediatric patients using minimally invasive techniques, which have become increasingly favored over traditional open-heart surgeries due to their reduced recovery times and lower risk of complications. Innovations such as bioresorbable stents, advanced balloon catheters, and next-generation closure devices have made it possible to perform intricate heart repairs with greater precision. Imaging technologies such as 3D echocardiography and advanced cardiac MRI systems are being integrated into pediatric interventions, allowing for better visualization and planning of complex procedures. Additionally, the miniaturization of devices has enabled more tailored interventions for younger children and infants, ensuring that these devices can be used effectively in smaller anatomies. These advancements not only improve the safety and effectiveness of procedures but also open the door to new treatment possibilities for pediatric patients with complex heart conditions.

Why Is the Demand for Pediatric Interventional Cardiology Devices Growing?

The demand for pediatric interventional cardiology devices is on the rise due to the increasing prevalence of congenital heart disease (CHD) worldwide. CHD remains the most common birth defect, affecting nearly 1% of live births globally, with many cases requiring medical intervention early in life. As diagnostic capabilities improve and more CHD cases are identified and treated earlier, the need for specialized pediatric cardiology devices continues to grow. Additionally, advancements in neonatal care and the ability to successfully treat very young and preterm infants have expanded the patient population requiring interventional cardiology procedures. Pediatric interventional cardiology devices provide minimally invasive treatment options, which are particularly important for this young and fragile patient population. The growing awareness of CHD and the push for earlier detection through improved screening methods are also contributing to increased demand. Furthermore, healthcare systems worldwide are recognizing the need for specialized pediatric cardiac care, prompting investments in pediatric cardiology programs and driving the market for interventional devices designed specifically for children.

How Are Patient Care Trends and Regulatory Approvals Shaping the Pediatric Cardiology Market?

Trends in patient-centered care and stringent regulatory requirements are shaping the pediatric interventional cardiology devices market. With the rise of personalized medicine, there is a growing focus on developing devices tailored to the unique needs of pediatric patients, particularly in terms of size, flexibility, and biocompatibility. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are putting greater emphasis on ensuring that devices intended for pediatric use meet strict safety and efficacy standards. This has led to an increase in clinical trials focused on pediatric applications, ensuring that devices are specifically tested for use in children rather than being adapted from adult devices. Additionally, the trend toward value-based healthcare is driving demand for devices that not only improve patient outcomes but also reduce long-term costs by minimizing the need for repeat interventions. As healthcare providers continue to focus on patient outcomes and the quality of life post-intervention, the demand for cutting-edge pediatric interventional cardiology devices that meet these criteria is increasing.

What Factors Are Driving Growth in the Pediatric Interventional Cardiology Devices Market?

The growth in the pediatric interventional cardiology devices market is driven by several factors, including technological innovations, the rising prevalence of congenital heart defects, and regulatory advancements. One key driver is the increasing use of minimally invasive techniques, which reduce the risks and recovery times associated with traditional surgeries, making these devices more attractive for treating children. Technological advancements, such as the development of bioresorbable stents and improved catheter systems, are enabling more effective and safer interventions. Additionally, the growing focus on early diagnosis of congenital heart diseases is boosting demand for these devices, as more children are being treated at younger ages. The rising investment in pediatric cardiology programs and research, along with government initiatives to improve neonatal and pediatric care, is further driving market expansion. Lastly, the increasing adoption of imaging technologies that improve the precision and outcomes of pediatric cardiac procedures is playing a significant role in the growth of this market, as healthcare providers continue to seek out advanced solutions that improve patient care.

SCOPE OF STUDY:

The report analyzes the Pediatric Interventional Cardiology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Congenital Heart Defect Closure Devices, Transcatheter Heart Valves, Other Segments)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â